See more : Bliss GVS Pharma Limited (BLISSGVS.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Fauvet Girel (FAUV.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fauvet Girel, a leading company in the Railroads industry within the Industrials sector.
- Shalby Limited (SHALBY.BO) Income Statement Analysis – Financial Results
- China Water Industry Group Limited (1129.HK) Income Statement Analysis – Financial Results
- Renjie Oldsichuan Catering Management Consultant Co., Ltd. (2741.TWO) Income Statement Analysis – Financial Results
- Divide Drives Inc. (DVDR) Income Statement Analysis – Financial Results
- Muthoot Capital Services Limited (MUTHOOTCAP.NS) Income Statement Analysis – Financial Results
Fauvet Girel (FAUV.PA)
About Fauvet Girel
As per the transaction announced on October 15, 2021, operates as a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 343.34K | 655.83K | 550.13K | 322.10K | 34.93K | 10.80K | 12.66K | 144.64K | 139.10K | 143.61K | 15.75K | 14.61K |
Cost of Revenue | 101.64K | 87.21K | 66.47K | 283.69K | 456.83K | 164.18K | 130.46K | 95.76K | 101.18K | 94.49K | 0.00 | 0.00 | 0.00 | 61.46K | 65.67K |
Gross Profit | -101.64K | -87.21K | -66.47K | 59.65K | 199.00K | 385.95K | 191.64K | -60.82K | -90.39K | -81.83K | 144.64K | 139.10K | 143.61K | -45.71K | -51.06K |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 17.37% | 30.34% | 70.16% | 59.50% | -174.11% | -837.29% | -646.37% | 100.00% | 100.00% | 100.00% | -290.28% | -349.36% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 114.66K | 0.00 | 79.21K | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 114.66K | 0.00 | 79.21K | 0.00 | 0.00 |
Other Expenses | 988.00 | 3.96K | 2.79K | 3.04K | 11.85K | 225.32K | 131.04K | -3.66K | -50.64K | -69.56K | 54.65K | 62.16K | 82.27K | -18.81K | -28.87K |
Operating Expenses | 988.00 | 3.96K | 2.79K | 3.04K | 11.85K | 225.32K | 131.04K | -3.66K | -50.64K | -69.56K | 169.32K | 62.16K | 161.47K | -18.81K | -28.87K |
Cost & Expenses | 102.62K | 91.16K | 69.26K | 286.74K | 468.68K | 389.50K | 261.50K | 92.10K | 50.54K | 24.94K | 169.32K | 62.16K | 161.47K | 42.65K | 36.80K |
Interest Income | 11.00 | 1.87K | 6.33K | 4.94K | 2.85K | 6.89K | 25.19K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 11.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 398.61K | 1.87K | 6.33K | -1.68M | 928.33K | 227.02K | 134.60K | 19.55K | 11.15K | 11.44K | 11.26K | 11.20K | 10.13K | 7.71K | 5.28K |
EBITDA | 295.97K | -89.30K | -62.94K | 460.68K | 903.23K | -271.97K | -282.99K | 1.01M | 733.64K | 181.31K | 77.24K | 65.61K | 93.36K | 197.92K | 167.52K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 134.18% | 137.72% | -49.44% | -87.86% | 2,894.95% | 6,796.14% | 1,432.18% | 53.40% | 47.17% | 65.01% | 1,256.77% | 1,146.30% |
Operating Income | -102.64K | -91.16K | -69.26K | 2.14M | -25.10K | -498.99K | -417.58K | 991.74K | 722.49K | 169.88K | 65.98K | 54.41K | 83.23K | 190.21K | 162.24K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 623.01% | -3.83% | -90.70% | -129.64% | 2,838.98% | 6,692.84% | 1,341.85% | 45.62% | 39.11% | 57.95% | 1,207.82% | 1,110.16% |
Total Other Income/Expenses | 29.00 | 1.87K | 6.33K | -2.08M | 215.10K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -305.00 | 0.00 | 18.05K | 0.00 | 0.00 |
Income Before Tax | -102.61K | -89.30K | -62.94K | 61.54K | 190.00K | -498.99K | -417.58K | 991.74K | 722.49K | 169.88K | 65.68K | 54.41K | 101.27K | 190.21K | 162.24K |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 17.93% | 28.97% | -90.70% | -129.64% | 2,838.98% | 6,692.84% | 1,341.85% | 45.41% | 39.11% | 70.52% | 1,207.82% | 1,110.16% |
Income Tax Expense | 38.09K | -1.87K | -6.33K | 516.73K | 215.10K | 0.00 | -136.65K | 333.12K | 242.94K | 58.69K | 24.06K | 20.18K | 29.82K | 65.48K | 55.41K |
Net Income | -140.70K | -87.43K | -56.61K | -455.18K | -25.10K | -498.99K | -280.93K | 658.62K | 479.56K | 111.19K | 41.61K | 34.23K | 71.45K | 124.73K | 106.83K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | -132.58% | -3.83% | -90.70% | -87.22% | 1,885.37% | 4,442.40% | 878.26% | 28.77% | 24.61% | 49.75% | 792.05% | 731.01% |
EPS | -0.56 | -0.35 | -0.23 | -1.81 | -0.10 | -2.00 | -1.00 | 3.00 | 2.00 | 0.44 | 0.17 | 0.14 | 0.28 | 0.50 | 0.43 |
EPS Diluted | -0.56 | -0.35 | -0.23 | -1.81 | -0.10 | -2.00 | -1.00 | 3.00 | 2.00 | 0.44 | 0.17 | 0.14 | 0.28 | 0.50 | 0.43 |
Weighted Avg Shares Out | 250.72K | 250.81K | 250.81K | 250.81K | 250.81K | 249.50K | 280.93K | 219.54K | 239.78K | 250.81K | 250.81K | 250.81K | 250.81K | 250.81K | 250.81K |
Weighted Avg Shares Out (Dil) | 250.72K | 250.81K | 250.81K | 250.81K | 250.81K | 249.50K | 280.93K | 219.54K | 239.78K | 250.81K | 250.81K | 250.81K | 250.81K | 250.81K | 250.81K |
Source: https://incomestatements.info
Category: Stock Reports